M.D. Minden

405 citations
16 papers · 289 · h-index 7

Impact in

Papers in

M.D. Minden

15 papers receiving 278 citations

Peers

M.D. Minden
Comparison fields: 5 of 56
  • Hematology 86
  • Cancer Research 87
  • Molecular Biology 152
  • Genetics 22
  • Immunology 41
Replace Kati Servan with:
Kati Servan Germany
Margit Stimpfl Austria
Limengmeng Wang China
O. I. Olopade United States
Zhen Shang China
K Kagami Japan
Daniel Onofre Vidal Brazil
Ling Sun China
Masafumi MURAI Japan
Devorah Olam Israel
M.D. Minden relative to Kati Servan Germany Kati Servan's profile →
Citations per field
00.5×1.5×
Kati Servan · 1×
Citations per year

Countries citing papers authored by M.D. Minden

Since Specialization
Citations

This map shows the geographic impact of M.D. Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Minden more than expected).

Fields of papers citing papers by M.D. Minden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.D. Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Minden. The network helps show where M.D. Minden may publish in the future.

Co-authors

The 25 scholars most cited alongside M.D. Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M.D. Minden Line = papers co-authored together M.D. Minden links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1 2001113
2 201553
3
Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
199547
4
Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
199427
5
Regulation of the synthesis of bcl-2 protein by growth factors.
199616
6
The influence of growth regulation on treatment strategy for acute myeloblastic leukaemia.
19907
7 20036
8
High-dose cytosine arabinoside remission induction for acute myelogenous leukemia: comparison of two regimens of remission maintenance.
19926
9 19865
10 19872
11 20042
12 20171
13 20191
14 20091
15 20101
16 20171

About M.D. Minden

M.D. Minden is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Oncology and Cancer Research, having authored 16 papers that have together received 289 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer Treatment and Pharmacology (1 paper), Galectins and Cancer Biology (1 paper), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Hematology (86 citations), Cancer Research (87 citations), Molecular Biology (152 citations), Genetics (22 citations) and Immunology (41 citations). M.D. Minden has collaborated with scholars based in Canada, Russia and Netherlands. Frequent co-authors include E. A. McCulloch, W. Wei‐Lynn Wong, Zhenlei Xia, Jim Dimitroulakos, Linda Z. Penn, Guisheng Yang, Zhenbo Hu, H. A. Messner, Cornelis A.M. van Bergen and Katja Zirlik. Their work appears in journals such as Journal of Clinical Oncology, Leukemia Research, Blood, Stem Cells and Acta Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact